Institute Director elected as a Fellow of the Royal Society
Institute Director, Prof Greg Hannon is among the new Fellows announced today by the Royal Society and chosen for their outstanding contributions to science.
The 50 newly-elected Fellows announced today join a list of scientists, engineers and technologists from the UK and Commonwealth. Past Fellows and Foreign Members have included Newton, Darwin and Einstein.
The Royal Society is a self-governing Fellowship made up of the most eminent scientists, engineers and technologists from the UK and the Commonwealth. Fellows and Foreign Members are elected for life through a peer review process on the basis of excellence in science.
For their outstanding contributions to research and innovation, both now and in the future, it gives me great pleasure to welcome the world’s best scientists into the ranks of the Royal Society.Sir Venki Ramakrishnan, President of the Royal Society
There are approximately 1,600 Fellows and Foreign Members, including around 80 Nobel Laureates. Each year up to 52 Fellows and up to 10 Foreign Members are elected from a group of around 700 candidates who are proposed by the existing Fellowship.
Sir Venki Ramakrishnan, President of the Royal Society, says: “Our Fellows are key to the Royal Society’s fundamental purpose of using science for the benefit of humanity. For their outstanding contributions to research and innovation, both now and in the future, it gives me great pleasure to welcome the world’s best scientists into the ranks of the Royal Society.”
The new Fellows will be formally admitted to the Society at the Admissions Day ceremony in July, when they will sign the Charter Book and the Obligation of the Fellows of the Royal Society.
Related News
See all news-
Sir Shankar Balasubramanian elected Fellow of the AACR Academy
10th March 2025
Sir Shankar has been recognised for his pioneering research in nucleic acid chemistry and his key role in the development of next-generation sequencing technology.
Find out more -
Richard Mair joins Institute as an Independent Clinical Fellow
10th February 2025
Richard will build a research group at the Institute to focus on IDH mutant astrocytoma, , a common type of brain tumour that accounts for 9% of brain tumour diagnoses.
Find out more -
Imaging technique allows rapid assessment of ovarian cancer subtypes and their response to treatment
6th December 2024
An MRI-based imaging technique developed at the Institute predicts the response of ovarian cancer tumours to treatment, and rapidly reveals how well treatment is working, in patient-derived cell models.
Find out more